Maryam Lustberg: Enrollment counts for federally sponsored trials were flat, rising substantially in industry trials

Maryam Lustberg posted the following on LinkedIn:

“Enrollment counts for federally sponsored trials were flat over the study period while rising substantially in industry-sponsored trials.”

Patient Enrollment to Industry-Sponsored Versus Federally Sponsored Cancer Clinical Trials

Authors:  Joseph M. Unger, Hong Xiao, Riha Vaidya, and Michael LeBlanc

Source: Maryam Lustberg/LinkedIn

Maryam Lustberg is the Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and Chief of Breast Medical Oncology at Yale Cancer Center. She is also an Associate Professor of Medicine (Medical Oncology). She has been recognized for her patient-focused care with awards that include being rated by Forbes as one of the top breast medical oncologists in the nation and named to the Castle Connolly list of “Regional Top Doctors,” and “Exceptional Women in Medicine” for 2020.

Dr. Lustberg is a member of the ASCO Annual Meeting Education Committee, Patient and Survivor Care Education Committee, and Neuropathy Expert Guideline Panel. She is the President and on the Board of Directors for the international organization Multinational Association of Supportive Care in Cancer (MASCC). She serves as an Associate Editor for the Journal of Cancer Survivorship.